These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29532329)

  • 1. Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS.
    Martin A; Payne R; Wilson EC
    Appl Health Econ Health Policy; 2018 Jun; 16(3):317-330. PubMed ID: 29532329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling.
    Miani C; Martin A; Exley J; Doble B; Wilson E; Payne R; Avery A; Meads C; Kirtley A; Jones MM; King S
    Health Technol Assess; 2017 Dec; 21(78):1-128. PubMed ID: 29268843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (<60 days) or long (≥60 days) prescription lengths in primary care for common, chronic conditions in the UK.
    Doble B; Payne R; Harshfield A; Wilson ECF
    BMJ Open; 2017 Dec; 7(12):e019382. PubMed ID: 29208621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of issuing longer- versus shorter-duration prescriptions: a systematic review.
    King S; Miani C; Exley J; Larkin J; Kirtley A; Payne RA
    Br J Gen Pract; 2018 Apr; 68(669):e286-e292. PubMed ID: 29530921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and carer experience of obtaining regular prescribed medication for chronic disease in the English National Health Service: a qualitative study.
    Wilson PM; Kataria N; McNeilly E
    BMC Health Serv Res; 2013 May; 13():192. PubMed ID: 23705866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK interventions to control medicines wastage: a critical review.
    White KG
    Int J Pharm Pract; 2010 Jun; 18(3):131-40. PubMed ID: 20509346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualisation or standardisation: trends in National Health Service prescription durations in England 1998-2009.
    Davies JE; Taylor DG
    Prim Health Care Res Dev; 2013 Apr; 14(2):164-74. PubMed ID: 23031628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term - a cluster randomised controlled trial and economic evaluation.
    Julious SA; Horspool MJ; Davis S; Bradburn M; Norman P; Shephard N; Cooper CL; Smithson WH; Boote J; Elphick H; Loban A; Franklin M; Kua WS; May R; Campbell J; Williams R; Rex S; Bortolami O
    Health Technol Assess; 2016 Dec; 20(93):1-154. PubMed ID: 28005003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting.
    Af Geijerstam P; Falster MO; Chalmers J; McLachlan AJ; Rodgers A; Schutte AE
    Hypertens Res; 2024 Aug; 47(8):2104-2114. PubMed ID: 38849500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of Shorter Initial Opioid Prescriptions: A Simulation Evaluation.
    Bjarnadóttir MV; Anderson DR; Prasad K; Agarwal R; Nelson DA
    Pharmacoeconomics; 2020 Jan; 38(1):109-119. PubMed ID: 31631255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prescription charges on repeat prescribing in primary care.
    Bradley F; Elvey R; Ashcroft DM; Noyce P
    J Clin Pharm Ther; 2007 Jun; 32(3):269-75. PubMed ID: 17489879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients.
    Hale A; Merlo G; Nissen L; Coombes I; Graves N
    BMC Health Serv Res; 2018 Oct; 18(1):749. PubMed ID: 30285744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
    Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
    BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist-led management of chronic pain in primary care: costs and benefits in a pilot randomised controlled trial.
    Neilson AR; Bruhn H; Bond CM; Elliott AM; Smith BH; Hannaford PC; Holland R; Lee AJ; Watson M; Wright D; McNamee P
    BMJ Open; 2015 Apr; 5(4):e006874. PubMed ID: 25833666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case study.
    Lomas J; Schmitt L; Jones S; McGeorge M; Bates E; Holland M; Cooper D; Crowther R; Ashmore M; Rojas-Rueda D; Weatherly H; Richardson G; Bojke L
    BMJ Open; 2016 Jun; 6(6):e010686. PubMed ID: 27329439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.
    Elliott RA; Tanajewski L; Gkountouras G; Avery AJ; Barber N; Mehta R; Boyd MJ; Latif A; Chuter A; Waring J
    Pharmacoeconomics; 2017 Dec; 35(12):1237-1255. PubMed ID: 28776320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower fragmentation of coordination in primary care is associated with lower prescribing drug costs-lessons from chronic illness care in Hungary.
    Lublóy Á; Keresztúri JL; Benedek G
    Eur J Public Health; 2017 Oct; 27(5):826-829. PubMed ID: 28957481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service.
    Elliott RA; Boyd MJ; Salema NE; Davies J; Barber N; Mehta RL; Tanajewski L; Waring J; Latif A; Gkountouras G; Avery AJ; Chuter A; Craig C
    BMJ Qual Saf; 2016 Oct; 25(10):747-58. PubMed ID: 26647412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.